FR12C0060I2 - Procede de fabrication de vaccins - Google Patents

Procede de fabrication de vaccins

Info

Publication number
FR12C0060I2
FR12C0060I2 FR12C0060C FR12C0060C FR12C0060I2 FR 12C0060 I2 FR12C0060 I2 FR 12C0060I2 FR 12C0060 C FR12C0060 C FR 12C0060C FR 12C0060 C FR12C0060 C FR 12C0060C FR 12C0060 I2 FR12C0060 I2 FR 12C0060I2
Authority
FR
France
Prior art keywords
manufacturing vaccines
vaccines
manufacturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR12C0060C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0513071.1A external-priority patent/GB0513071D0/en
Priority claimed from GB0515556A external-priority patent/GB0515556D0/en
Priority claimed from GB0524204A external-priority patent/GB0524204D0/en
Priority claimed from GB0526041A external-priority patent/GB0526041D0/en
Priority claimed from GB0526040A external-priority patent/GB0526040D0/en
Priority claimed from PCT/EP2006/006270 external-priority patent/WO2007000343A2/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of FR12C0060I1 publication Critical patent/FR12C0060I1/fr
Application granted granted Critical
Publication of FR12C0060I2 publication Critical patent/FR12C0060I2/fr
Active legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR12C0060C 2005-06-27 2012-10-18 Procede de fabrication de vaccins Active FR12C0060I2 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB0513071.1A GB0513071D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0515556A GB0515556D0 (en) 2005-07-28 2005-07-28 Immunogenic composition
GB0524204A GB0524204D0 (en) 2005-11-28 2005-11-28 Immunogenic composition
GB0526041A GB0526041D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
GB0526040A GB0526040D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
PCT/EP2006/006270 WO2007000343A2 (en) 2005-06-27 2006-06-23 Process for manufacturing vaccines

Publications (2)

Publication Number Publication Date
FR12C0060I1 FR12C0060I1 (enrdf_load_stackoverflow) 2012-12-14
FR12C0060I2 true FR12C0060I2 (fr) 2017-01-06

Family

ID=34856207

Family Applications (1)

Application Number Title Priority Date Filing Date
FR12C0060C Active FR12C0060I2 (fr) 2005-06-27 2012-10-18 Procede de fabrication de vaccins

Country Status (7)

Country Link
CN (4) CN101247827B (enrdf_load_stackoverflow)
ES (1) ES2367918T5 (enrdf_load_stackoverflow)
FR (1) FR12C0060I2 (enrdf_load_stackoverflow)
GB (1) GB0513069D0 (enrdf_load_stackoverflow)
NO (2) NO2021022I1 (enrdf_load_stackoverflow)
UA (1) UA97233C2 (enrdf_load_stackoverflow)
ZA (3) ZA200710853B (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104302315B (zh) * 2012-01-30 2018-02-06 印度血清研究所私人有限公司 免疫原性组合物及其制备方法
PL2885007T3 (pl) * 2012-08-16 2019-02-28 Pfizer Inc. Sposoby glikokoniugacji i kompozycje
CA3033364A1 (en) * 2016-09-02 2018-03-08 Sanofi Pasteur, Inc. Neisseria meningitidis vaccine
US20230137914A1 (en) * 2016-11-25 2023-05-04 Glaxosmithkline Biologicals, S.A. nOMV-ANTIGEN CONJUGATED COMPOUNDS AND USE THEREOF
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
WO2021099982A1 (en) * 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
CN115819616B (zh) * 2021-07-28 2025-04-11 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
WO2002000249A2 (en) * 2000-06-29 2002-01-03 Glaxosmithkline Biologicals S.A. Multivalent vaccine composition
WO2002080964A1 (en) * 2001-04-06 2002-10-17 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖－蛋白结合疫苗
PT2172213E (pt) * 2003-01-30 2013-06-03 Novartis Ag Vacinas injetáveis contra múltiplos serogrupos meningocócicos

Also Published As

Publication number Publication date
CN101222935B (zh) 2015-07-29
CN101222935A (zh) 2008-07-16
CN101208103B (zh) 2013-04-24
UA97233C2 (uk) 2012-01-25
ZA200710909B (en) 2009-04-29
CN101247827A (zh) 2008-08-20
ZA200711074B (en) 2009-07-29
FR12C0060I1 (enrdf_load_stackoverflow) 2012-12-14
CN101208103A (zh) 2008-06-25
CN101208101B (zh) 2013-01-02
CN101247827B (zh) 2013-07-17
NO2021022I1 (no) 2021-05-25
ZA200710853B (en) 2009-04-29
GB0513069D0 (en) 2005-08-03
CN101208101A (zh) 2008-06-25
NO2025018I1 (no) 2025-04-08
ES2367918T5 (es) 2014-11-21
ES2367918T3 (es) 2011-11-10

Similar Documents

Publication Publication Date Title
HUS1200023I1 (hu) Eljárás vakcinák elõállítására
FR12C0060I2 (fr) Procede de fabrication de vaccins
EP1983636A4 (en) Rotor manufacturing method
GB0700136D0 (en) Process for manufacturing vaccines
EP2074445A4 (en) METHOD FOR PRODUCING AN ADJUSTABLE LENS
EP1952908A4 (en) PROCESS FOR THE MANUFACTURE OF MOLDS
EP2000440A4 (en) METHOD OF MANUFACTURING GLASS
FR2902785B1 (fr) Procede de fabrication de 1,2-dichloroethane
FR2903983B1 (fr) Procede de fabrication de diesters.
FR2902787B1 (fr) Procede de fabrication de 1,2-dichloroethane
FR2902786B1 (fr) Procede de fabrication de 1,2-dichloroethane
DE602006020716D1 (de) Kastenloses formverfahren
FR2870231B1 (fr) Procede de fabrication de vitroceramique
FR2902784B1 (fr) Procede de fabrication de 1,2-dichloroethane
DE602006004399D1 (de) Schleifverfahren
EP1961699A4 (en) PROCESS FOR THE PREPARATION OF CHLORINE
EP1867627A4 (en) Process for production of tertiary amines
FR2908423B1 (fr) Procede de fabrication de biere.
EP1925019A4 (en) NANO-FORM PROCESS
FR2876998B1 (fr) Procede de preparation de gamma-liv205
FR2895286B1 (fr) Procede de broyage
FR2865480B1 (fr) Procede de fabrication de surfaces non tissees
FR2894958B1 (fr) Procede de preparation de difluoroethanol
FI20050208L (fi) Menetelmä uusien tuotteiden valmistamiseksi
FR2902788B1 (fr) Procede de fabrication du pentafluoroethane